Ruthenium Organic Compounds TRIZ Cases

New bipyridine ruthenium dyes achieve over 85% light-to-electricity conversion efficiency by reducing semiconductor layer porosity while maintaining stability.

Hybrid amine ligands allow ruthenium catalysts to operate in aprotic solvents, expanding substrate scope beyond protonic solvent constraints.

A metal complex dye with specific ligand coordination enhances incident photon-to-current efficiency in long wavelength regions.

Electron pair donors complex aluminum by-products from the reaction of alkali metal hydrides with azulene, enabling high-purity dihydroazulenide production.

Synthetic biomimetic catalysts enable ex vivo prediction of in vivo drug metabolism through oxidative metabolite formation.

Quaternary onium groups in metathesis catalysts enable rapid heavy metal removal via silica gel filtration, solving purification bottlenecks.

Ruthenium alkylidene metathesis catalyst reduces catalyst loading and improves selectivity for terminal olefin production from internal olefins.

Contacting a Group 8 transition metal precursor with an acetylenic compound containing a chelating moiety forms an active olefin metathesis catalyst in situ.

An alkynyl-modified ruthenium complex with a DPPZ ligand improves cellular uptake through Sonogashira coupling synthesis.

In situ ruthenium catalyst with phenol derivatives resolves recycling lifetime issues while maintaining high turnover frequency in menthone production.

Cross metathesis of penta-coordinated ruthenium alkylidene complexes eliminates phosphine ligands and copper contamination, achieving 80-95% yields.

Tunable metal-based thiophene compounds absorb visible light to cleave intracellular nuclear DNA through Type 1 or Type 2 photoprocesses.

Sulfonated diamine ligands on tethered eta6 arene ruthenium complexes resist deactivation by polyfunctional groups while maintaining high enantiomeric excess.

Segmented ruthenium complexes balance high catalytic activity with recyclability, minimizing toxic metal residue contamination in pharmaceutical synthesis.

A divinylazobenzene-bridged diruthenium complex enables regio- and stereospecific insertion into terminal alkyne bonds.

Luminescent metal complexes detect proteins with high sensitivity by suppressing background noise through hydrophobic and electrostatic interactions.

Chiral C-H activated ruthenium complexes achieve high enantioselectivity and Z-selectivity in asymmetric ring opening cross metathesis reactions.

In situ chiral ruthenium catalysts minimize olefin waste and safety hazards by enabling high-yield stereoselective cyclopropanation with minimal reagent excess.

A strongly-polarized molecule bridges graphene nanogaps via amide covalent bonds to form a single molecule field effect transistor.

Surface immobilized catalysts use condensation reactions to generate robust pyrazine moieties on graphitic carbon.

Novel ruthenium complex featuring a ruthenacycle structure enhances catalytic activity in asymmetric reduction reactions.

Novel ruthenium carbonyl complex featuring a tridentate aminodiphosphine ligand enables efficient catalytic hydrogenation of ketones, esters, and lactones.

SKEWPHOS-based ruthenium catalyst resolves low optical purity and reactivity trade-offs in 3-quinuclidinol synthesis.

Ethyne-bridged chromophores absorb visible light across a broad spectral range, extending excited-state lifetimes to drive efficient energy conversion.

A ruthenium complex photosensitizer dye aligns its absorption spectrum with solar radiation to enhance light capture.

Replacing expensive alkamine precursors with amino alcohols reduces synthesis costs while maintaining high catalytic activity and substrate scope.

Electron-withdrawing aryl groups weaken Ru-N bonds in ruthenium catalysts, enabling high activity at lower temperatures and simplifying precursor synthesis.

Reacting a ruthenium dimer with an amine ligand in primary alcohol solvent yields the target complex as a single isomer.

Chiral Group 8 transition metal carbene complexes resolve the trade-off between enantioselectivity and catalyst complexity in asymmetric metathesis reactions.

Novel ruthenium or osmium complexes combine phosphine and NHC ligands to deliver high catalytic activity without co-catalysts.

Heating ruthenium complexes in sealed vessels with lower boiling point aromatics resolves equipment complexity constraints while preventing decomposition.

Ruthenium(II) complexes coordinate with nucleic acids to alter their morphology and enable transmembrane transport into viable cells.

Polycycloolefin encapsulants match organic layer refractive indices to boost photon extraction while resisting premature polymerization.

A caged antisense oligonucleotide uses a ruthenium photolinker to expose hybridization sites upon irradiation.

A novel oxa-spirodiphosphine ligand forms a ruthenium complex that catalyzes asymmetric hydrogenation reactions.

Surfactant-mediated micelles solubilize hydrophobic chiral ligands, enabling asymmetric hydrogenation without expensive organic solvent modifications.

Asymmetric planar aromatic compounds stabilize guanine quadruplexes through specific structural interactions.

CNC-pincer ligands modulate electron density at metal centers, resolving poor selectivity and limited durability in benchmark catalysts.

A ruthenium complex with a four-carbon linker enhances catalytic activity in asymmetric hydrogenation reactions.

Bisstyryl-bipyridine ruthenium complexes absorb light between 450 and 900 nm via one- or two-photon excitation.

Modified organoruthenium complexes stabilize in air and moisture while delivering high catalytic activity upon activation.

Ditopic ligand Group 8 catalysts resolve initiation rate control and stability trade-offs through latent precursors activated by light or chemicals.

Immobilized ruthenium triphos catalyst overcomes poor recyclability and short lifetimes of molecular systems, enabling efficient amide conversion.

A ruthenium-triphos-(OMe)2 organometallic complex facilitates the conversion of amides to amines and alcohols.

Novel ruthenium complex photosensitizers enhance solar light absorption and electron transfer in dye-sensitized solar cells.

A ruthenium oxalato cluster inhibits HIV-1 replication and reverse transcriptase activity.